T3	Pharmacological_substance 1943 1950	FG-3019
T5	Anatomical_entity 1603 1607	lung
T13	Disorder 62 78	fibrotic disease
T15	Negative_regulation 1584 1593	reduction
T19	GGPs 1818 1823	TGF-β
T22	Pharmacological_substance 903 910	FG-3019
T25	Disorder 611 614	UUO
T26	Pharmacological_substance 1541 1548	FG-3019
T28	Artificial_process 1134 1148	administration
T29	GGPs 36 41	TGF-β
T30	GGPs 1315 1320	TGF-β
T32	Artificial_process 1648 1657	treatment
T34	Anatomical_entity 1072 1077	liver
T40	GGPs 557 561	CTGF
T42	GGPs 1809 1813	CTGF
T44	GGPs 239 242;243 245	TGF -β
T45	Pharmacological_substance 1401 1408	FG-3019
T49	Anatomical_entity 1863 1869	tissue
T52	Disorder 691 709	pulmonary fibrosis
T53	Disorder 1465 1468	UUO
T55	GGPs 765 771	TGF-β2
T56	GGPs 27 31	CTGF
T60	Disorder 2037 2063	fibroproliferative disease
T64	Pharmacological_substance 1631 1647	FG-3019 antibody
T66	Pharmacological_substance 843 869	anti-CTGF antibody FG-3019
T67	Artificial_process 1995 2014	therapeutic benefit
T74	GGPs 756 760	CTGF
T81	GGPs 126 130	CTGF
T83	Disorder 616 630	renal fibrosis
T84	Subject 837 842	human
T85	GGPs 380 384	CTGF
T86	Subject 1505 1512	animals
T89	Anatomical_entity 1426 1431	renal
T100	GGPs 211 237;243 245	transforming growth factor -β
T108	GGPs 1236 1240	CTGF
T110	Pharmacological_substance 1487 1496	bleomycin
T111	GGPs 566 572	TGF-β2
T112	Anatomical_entity 388 394	tissue
T113	GGPs 1374 1378	CTGF
T114	GGPs 93 124	Connective tissue growth factor
T116	Subject 429 441	three murine
T119	Anatomical_entity 1043 1049	kidney
T120	GGPs 1159 1167	cytokine
T121	Anatomical_entity 1103 1107	lung
T126	GGPs 1689 1697	collagen
E2	Negative_regulation:T15 atLoc:T5 Cause:T26 Theme:T50
E5	Artificial_process:T28 Instrument:T120
E6	Artificial_process:T32 Instrument:T64 Theme:T87
E8	Artificial_process:T67 Instrument:T3 Theme:T60
N9	Reference T3 UMLS:C2985186	FG 3019
N22	Reference T5 UMLS:C0024109	Lung
N78	Reference T22 UMLS:C2985186	FG 3019
N87	Reference T25 UMLS:C0041956	Ureteral obstruction
N90	Reference T26 UMLS:C2985186	FG 3019
N100	Reference T29 UMLS:C0040691	Transforming Growth Factors
N116	Reference E6 UMLS:C0087111	Therapeutic procedure
N126	Reference T34 UMLS:C0023884	Liver
N158	Reference T42 UMLS:C0110610	connective tissue growth factor
N168	Reference T45 UMLS:C2985186	FG 3019
N180	Reference T49 UMLS:C0040300	Body tissue
N192	Reference T52 UMLS:C0034069	Pulmonary Fibrosis
N194	Reference T53 UMLS:C0041956	Ureteral obstruction
N202	Reference T55 UMLS:C0040691	Transforming Growth Factors
N206	Reference T56 UMLS:C0110610	connective tissue growth factor
N236	Reference T64 UMLS:C2985186	FG 3019
N245	Reference T66 UMLS:C2985186	FG 3019
N249	Reference E8 UMLS:C0302350	Therapeutic
N277	Reference T74 UMLS:C0110610	connective tissue growth factor
N278	Reference T74 UMLS:C1413791	CTGF gene
N296	Reference T81 UMLS:C0110610	connective tissue growth factor
N303	Reference T83 UMLS:C0151650	Renal fibrosis
N306	Reference T84 UMLS:C0086418	Homo sapiens
N309	Reference T85 UMLS:C0110610	connective tissue growth factor
N325	Reference T89 UMLS:C0022646	Kidney
N402	Reference T110 UMLS:C0005740	Bleomycin
N408	Reference T112 UMLS:C0040300	Body tissue
N419	Reference T114 UMLS:C0110610	connective tissue growth factor
N433	Reference T119 UMLS:C0022646	Kidney
N439	Reference T120 UMLS:C0079189	cytokine
N443	Reference T121 UMLS:C0024109	Lung
N455	Reference T126 UMLS:C0009325	Collagen
T27	Pathway 0 23	Cooperative interaction
E11	Pathway:T27 atLoc:T37 Participant:T56 Participant2:T29
T12	Positive_regulation 153 160	promote
E4	Positive_regulation:T12 Cause:E13 Theme:E12
T31	Biological_process 165 188	development of fibrosis
E12	Biological_process:T31 
T8	Pathway 192 205	collaboration
E13	Pathway:T8 Participant:T114 Participant2:T100
T43	Disorder 452 468	fibrotic disease
N5	Reference T43 UMLS:C0016059	Fibrosis
A3	Count_sbjct T116
A4	Organism_sbjct T116 Organism
A5	Patient_sbjct T116 Patient
T36	Regulation 366 376	importance
E15	Regulation:T36 Cause:T85 Theme:E41
T18	Method_cue 527 553	intraperitoneal injections
N2	Reference T18 UMLS:C0021493	Injections, Intraperitoneal
T33	Positive_regulation 507 514	induced
E3	Positive_regulation:T33 Cause:T111 Theme:E42
E9	Positive_regulation:T33 Cause:T40 Theme:E42
T54	Disorder 578 609	unilateral ureteral obstruction
T65	Pharmacological_substance 659 668	bleomycin
T70	Artificial_process 645 658;669 681	intratracheal instillation
E16	Artificial_process:T70 Instrument:T65 Theme:T52
N6	Reference E16 UMLS:C1555389	Instillation, intratracheal
T7	Disorder 589 609	ureteral obstruction
N7	Reference T7 UMLS:C0041972	Urethral Obstruction
R6	Subject_Disorder Arg1:T116 Arg2:T83	
R7	Subject_Disorder Arg1:T116 Arg2:T52	
T76	Artificial_process 720 752	Intraperitoneal coadministration
E18	Artificial_process:T76 Instrument:T74 Instrument2:T55
T39	Positive_regulation 772 780	elicited
E17	Positive_regulation:T39 Cause:T55 Theme:E14
T75	Negative_regulation 820 829	inhibited
E19	Negative_regulation:T75 Cause:T66 Theme:E14
E21	Positive_regulation:T39 Cause:T74 Theme:E14
T69	Negative_regulation 962 968	reduce
E22	Negative_regulation:T69 Cause:T22 atLoc:T121 Theme:T68
T71	Positive_regulation 914 924	ameliorate
E23	Positive_regulation:T71 Cause:T22 Theme:E43
E26	Negative_regulation:T69 Cause:T22 atLoc:T34 Theme:T68
E27	Negative_regulation:T69 Cause:T22 atLoc:T119 Theme:T68
T16	Negation_cue 1174 1180	failed
T62	Positive_regulation 1184 1190	elicit
E20	Positive_regulation:T62 Cause:T120 Cue:T16 Theme:E44
A8	Negated E20
T35	Positive_regulation 1278 1286	initiate
E7	Positive_regulation:T35 Cause:T108 Theme:E40
T4	Negative_regulation 1414 1421	reduced
E10	Negative_regulation:T4 Cause:T45 atLoc:T89 Theme:T73
T41	Positive_regulation 1358 1369	requirement
E24	Positive_regulation:T41 Cause:T113 Theme:E39
T23	Artificial_process 1549 1565	treatment effect
E25	Artificial_process:T23 Instrument:T26 Theme:T50
N13	Reference E25 UMLS:C0087111	Therapeutic procedure
T87	Subject 1756 1762	models
T10	Negative_regulation 1671 1678	reduced
E29	Negative_regulation:T10 Cause:T64 Theme:E45
T57	Localization 1698 1708	deposition
E30	Localization:T57 Theme:T126 atLoc:T87
E31	Negative_regulation:T10 Cause:T64 Theme:E30
T72	Pathway 1824 1833	signaling
E33	Pathway:T72 Participant:T19
T63	Pathway 1776 1800	Cooperative interactions
E32	Pathway:T63 Theme2:E37 Participant:T42
T78	Positive_regulation 1838 1846	required
E36	Positive_regulation:T78 Cause:E32 Theme:E46
T102	Method_cue 1965 1982	anti-CTGF therapy
N3	Reference T13 UMLS:C0016059	Fibrosis
N19	Reference T100 UMLS:C0040690	Transforming Growth Factor beta
N21	Reference T44 UMLS:C0040690	Transforming Growth Factor beta
N25	Reference T40 UMLS:C0117759	Ctgf protein, mouse
N26	Reference T111 UMLS:C1699343	Tgfb2 protein, mouse
N27	Reference T65 UMLS:C0005740	Bleomycin
N32	Reference T30 UMLS:C0040690	Transforming Growth Factor beta
N31	Reference T108 UMLS:C0110610	connective tissue growth factor
N33	Reference T113 UMLS:C0117759	Ctgf protein, mouse
N36	Reference T86 UMLS:C0003062	Animals
N40	Reference T19 UMLS:C0040690	Transforming Growth Factor beta
N42	Reference T60 UMLS:C0866674	Proliferative fibromatosis
T1	Biological_process 1918 1939	anti-fibrotic effects
E1	Biological_process:T1 Theme:T3
T14	Biological_process 1391 1399	fibrosis
E39	Biological_process:T14 
N41	Reference E39 UMLS:C0596570	fibrogenesis
T20	Biological_process 1287 1295	fibrosis
E40	Biological_process:T20 Participant:T30
N43	Reference E40 UMLS:C0596570	fibrogenesis
N17	Reference E12 UMLS:C0596570	fibrogenesis
T17	Biological_process 395 403	fibrosis
E41	Biological_process:T17 Theme:T112
N44	Reference E41 UMLS:C0596570	fibrogenesis
T21	Biological_process 487 506	multiorgan fibrosis
E42	Biological_process:T21 
N45	Reference E42 UMLS:C0596570	fibrogenesis
T48	Biological_process 793 810	fibrotic response
E14	Biological_process:T48 
N23	Reference E14 UMLS:C0596570	fibrogenesis
T6	Biological_process 949 957	fibrosis
E43	Biological_process:T6 
N12	Reference E43 UMLS:C0596570	fibrogenesis
T58	Biological_process 1193 1210	fibrotic response
E44	Biological_process:T58 
N46	Reference E44 UMLS:C0596570	fibrogenesis
T59	Biological_process 1740 1748	fibrosis
E45	Biological_process:T59 
N14	Reference E45 UMLS:C0596570	fibrogenesis
T46	Biological_process 1870 1878	fibrosis
E46	Biological_process:T46 Theme:T49
N47	Reference E46 UMLS:C0596570	fibrogenesis
T9	Cellular_process 1497 1504	injured
E28	Cellular_process:T9 Cause:T110 atLoc:T86
N11	Reference E28 UMLS:C0599732	cell injury
T50	Measurement 1597 1611	total lung Hyp
T68	Measurement 993 1032	hydroxyproline:proline (Hyp:Pro) ratios
T73	Measurement 1432 1448	Hyp:Pro response
N1	Reference E18 UMLS:C1621583	Administer
N10	Reference E5 UMLS:C1621583	Administer
T2	Pathway 1818 1833	TGF-β signaling
E37	Pathway:T2 Participant:T19
N16	Reference E37 UMLS:C1515163	TGF Beta Signaling Pathway BioCarta
N39	Reference E33 UMLS:C0037080	Signal Pathways
T37	Subject 45 51	animal
A11	Organism_sbjct T37 Organism
A13	Patient_sbjct T37 Patient
N49	Reference E4 UMLS:C1879547	Activation
N50	Reference E3 UMLS:C1879547	Activation
N51	Reference E9 UMLS:C1879547	Activation
N52	Reference E21 UMLS:C1879547	Activation
N53	Reference E17 UMLS:C1879547	Activation
N54	Reference E23 UMLS:C1879547	Activation
N55	Reference E20 UMLS:C1879547	Activation
N57	Reference E7 UMLS:C1879547	Activation
N58	Reference E24 UMLS:C1879547	Activation
N59	Reference E15 UMLS:C1327622	Regulation of biological process
N8	Reference E19 UMLS:C3463820	Inhibition
N61	Reference E22 UMLS:C3463820	Inhibition
N62	Reference E26 UMLS:C3463820	Inhibition
N63	Reference E27 UMLS:C3463820	Inhibition
N64	Reference E10 UMLS:C3463820	Inhibition
N56	Reference E2 UMLS:C3463820	Inhibition
N65	Reference E29 UMLS:C3463820	Inhibition
N66	Reference E31 UMLS:C3463820	Inhibition
R10	part_of Arg1:T112 Arg2:T116	
A14	Organism_sbjct T87 Organism
A15	Patient_sbjct T87 Patient
R4	Subject_Disorder Arg1:T37 Arg2:T13	
N37	Reference E30 UMLS:C1744691	establishment and maintenance of localization
N4	Reference E11 UMLS:C0037080	Signal Pathways
N18	Reference E13 UMLS:C0037080	Signal Pathways
N28	Reference E32 UMLS:C0037080	Signal Pathways
N38	Reference E36 UMLS:C1879547	Activation action
N15	Reference T37 UMLS:C0030705	Patients
N24	Reference T116 UMLS:C0030705	Patients
N48	Reference T87 UMLS:C0030705	Patients
N60	Reference T16 UMLS:C1518422	Negation
